| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 5e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |